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ABSTRACT
Objective UK primary care databases, which contain
diagnostic, demographic and prescribing information for
millions of patients geographically representative of the
UK, represent a signiﬁcant resource for health services
and clinical research. They can be used to identify
patients with a speciﬁed disease or condition
(phenotyping) and to investigate patterns of diagnosis
and symptoms. Currently, extracting such information
manually is time-consuming and requires considerable
expertise. In order to exploit more fully the potential of
these large and complex databases, our interdisciplinary
team developed generic methods allowing access to
different types of user.
Materials and methods Using the Clinical Practice
Research Datalink database, we have developed an
online user-focused system (TrialViz), which enables
users interactively to select suitable medical general
practices based on two criteria: suitability of the patient
base for the intended study (phenotyping) and measures
of data quality.
Results An end-to-end system, underpinned by an
innovative search algorithm, allows the user to extract
information in near real-time via an intuitive query
interface and to explore this information using interactive
visualization tools. A usability evaluation of this system
produced positive results.
Discussion We present the challenges and results in
the development of TrialViz and our plans for its
extension for wider applications of clinical research.
Conclusions Our fast search algorithms and simple
query algorithms represent a signiﬁcant advance for
users of clinical research databases.
BACKGROUND AND SIGNIFICANCE
Opportunities for the secondary use of routinely
collected data for research purposes have increased
enormously in recent years due to the wide uptake
and advances in technology; for example, elec-
tronic health records (EHR). The continued expan-
sion of large databases of patient records, often
linked to other sources of data, has greatly
enhanced the possibilities for using these records
for health services and clinical research.
Most people in the UK are registered with a
general practitioner (GP) who is the ﬁrst port of
call if they have a health problem. GPs act as the
‘gatekeeper’ to the National Health Service (NHS),
which is free at the point of use. They deal with
minor ailments locally, but refer patients for further
tests or care if the problem appears to be more
serious or cannot be treated within the practice.
All general practice encounters are recorded elec-
tronically and practitioners are encouraged to make
these records available for research. The Clinical
Practice Research Datalink (CPRD) database repre-
sents the largest collection of anonymized primary
care patient records in the world.1 Data are col-
lected from 5.5 million currently registered patients
(approximately 9% of the UK population). These
data are used worldwide by academics, govern-
ments and the pharmaceutical industry for health
services and clinical research.
However, extracting relevant information
(feature extraction or phenotyping2) from this data-
base is often difﬁcult and time-consuming. Each
patient may have thousands of records often with
multiple events occurring on the same day.
Although these records are rich in information, in
common with most data collected for non-research
purposes, records are variable in quality and may
be missing or incomplete. The present use of EHR
databases requires programing expertise and under-
standing of the nuances of the coding systems.
Queries may take hours or even days to run, and
once obtained the only way most researchers can
view the results is to scroll through hundreds of
records in tabular form.
OBJECTIVES
Our goal is to develop methods that will make the
information in these databases accessible to differ-
ent types of users, including those with little
expertise or those with little understanding of the
underlying data models and/or nuanced coding
schemes. In this project we developed methods to
allow users to identify patients suitable for further
screening for recruitment into randomized con-
trolled trials (RCT) within general practices.
TrialViz is a simple online intuitive interface to the
large and complex data held within CPRD. With
simple yet powerful interactive tools to build
complex trial protocols, TrialViz enables users to
select suitable GP practices based on two criteria:
suitability of the patient base for the intended study
(phenotyping) and practice-based measures of the
quality of data recording. Demographic and clinical
parameters (such as test results) supplement the
coded data to provide feasibility data in terms of
practice quality and potential recruitment rates. We
aim to represent the disease prevalence components
in real time, thus enabling a ﬂexible, rapid analysis
of study feasibility under a range of different
assumptions and choices. In this paper we describe
the challenges and results in the development of
Tate AR, et al. J Am Med Inform Assoc 2013;0:1–7. doi:10.1136/amiajnl-2013-001847 1
Research and applications
 Copyright 2013 by American Medical Informatics Association.
 group.bmj.com on November 25, 2013 - Published by jamia.bmj.comDownloaded from 
the system, our usability evaluation of the TrialViz tool and our
plans for its further development for wider applications of clin-
ical research.
MATERIALS AND METHODS
The database
CPRD (formerly the General Practice Research Database) is the
world’s largest validated computerized database of anonymized
longitudinal medical records for primary care.1 Data comprise
approximately 14 million patients with around 5.4 million of
these being currently alive and registered from 660 primary care
practices spread throughout the UK. CPRD is used worldwide
for research by the pharmaceutical industry, clinical research
organizations, regulators, government organizations and leading
academic institutions.
Records are derived from a widely used GP software system
(VISION) and contain complete prescribing and coded diagnos-
tic and clinical information as well as information on tests
requested, laboratory results and referrals made at or following
on from each consultation (ﬁgure 1). Each clinical event has a
code assigned by the GP using the Read coding system, V.2.3
Read codes are a hierarchical recording system used to record
clinical summary information and are not limited to diagnostic
and procedural codes, but also include codes for symptoms, test
results, screening, history and other areas. CPRD currently
includes approximately 4 billion records originally extracted
from primary care practices, in 1/2 terabyte of relational data.
This data volume will increase over time with the introduction
of further sources, including cancer registries (with information
on the grade and stage of the cancer), death and birth registries,
hospital episode statistics and socioeconomic class information.
Methods
Our multidisciplinary team of data analysts, epidemiologists, sta-
tisticians, graphical designers, software engineers, and computer
scientists developed:
1. Data abstraction tools – presented via an intuitive user inter-
face whereby users can upload or select codes/codelists and
create rules or queries for selecting the patients of interest.
2. Data extraction tools for running queries using the data
abstraction rules in near real time.
3. A protocol for measuring data quality for each practice and
its ﬁtness for a particular study.
4. Visualization tools to investigate the results.
These tools have been developed as part of a web-based
system ‘TrialViz’, funded by the UK Technology Strategy Board.
This system will enable research organizations and pharmaceut-
ical companies to undertake feasibility assessments to identify
suitable patients within GP practices for recruitment into clinical
trials, based on the available number of patients and the data
quality of the practice.
Data abstraction
One of the main challenges of working with UK GP data is the
number and complexity of the queries that need to be carried
out in order to sift out relevant information from the mass of
(mainly irrelevant) data. There may be thousands of records for
each patient, and there may be numerous codes for each disease
or type of symptom representing essentially the same thing. For
example, there are over 200 codes for diabetes and 40 codes
representing ‘abdominal pain’. Before carrying out an analysis
using GP data the user must draw up code lists, that is, a com-
prehensive set of condition-speciﬁc medical or drug codes that
can be used to search patient medical/clinical and prescription
records.4 After constructing the code list, the user must develop
a set of rules for extracting patients and events of interest and
write queries to merge all the relevant tables and extract records
for particular patients or events. This non-trivial task requires
considerable expertise. Many analysts use statistical software to
manage and extract the information, a minority use a database
query language such as SQL. Because running these queries may
take hours, or even days, analysts normally work on a small
subset of the data.
Data extraction
Another major challenge is the process time involved in running
queries. For data to be explored in an interactive and robust
manner, results of queries should be returned in real or near
real time. Most SQL-based systems that exist at present are not
capable in general of doing this. SQL is known to be erratic
when working with large datasets, that is, if the parser decides
to execute a query in an inefﬁcient manner, large data volumes
tend to exacerbate the delinquent behavior, resulting in query
execution time of several hours or days rather than expected
seconds. Thus it is often not possible to estimate in advance
how long each query will take. It is also important to note that
the ability to conduct large dataset research in real time in prin-
ciple is a very recent phenomenon, because storage capabilities
Figure 1 Primary care database overview.
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necessary to do so, such as solid state drives, only recently
became affordable for general research use.
Data quality assurance
In any application based on data, it is very important to ensure
that the data are of high quality. For example, it is unethical to
enrol patients into an experiment in which poor quality data
collection could lead to invalid results. Poor quality data lead to
poor searches with low efﬁciency for screening visits. Thus, data
quality, which we deﬁne as ﬁtness for use, is a ‘sine qua non’ for
the use of EHR in RCT. Investigation and monitoring of data
quality is a key component of the TrialViz project. Although
many books and articles have been written about data quality in
general, there exists no commonly accepted methodology for
deﬁning and comparing data quality in medical databases used
for research.5 6 Thus developing such a protocol formed an
important part of this work.
The work was carried out in several iterations, starting with a
preliminary investigation of basic and easily measurable criteria.
After a review of the literature, we selected a suitable framework
for monitoring data quality (that of the UK audit commission)
and used this to help deﬁne more complex and study-speciﬁc
aspects of data quality. The results of this investigation were
used to develop a protocol for characterizing and monitoring
the data quality of practices contributing data to the CPRD
(manuscript in preparation). Protocol development was
informed by the results of an investigation of data quality in all
629 practices contributing data to the CPRD each year between
2000 and 2010. We extracted simple ratios (ie, number of
desired outcomes/total number of outcomes)7 on general mea-
sures such as missing dates or codes, and study-speciﬁc measures
related to diabetes and coronary heart disease, for example,
completeness of relevant test results. The distributions of these
variables (the ratios) and their interrelationships were investi-
gated using summary statistics, graphs (histograms, boxplots and
scatterplots) and correlation analysis.
User evaluation
An inherent part of any software application development is a
strong user involvement at all stages of the development cycle,
from the conception of requirements speciﬁcation, through the
prototype testing to the usability evaluation. The TrialViz team
has ensured a continuous stakeholder involvement throughout
the development process, with regular user group meetings, at
which academic medical researchers, medical statisticians,
primary care research network members, clinical trial facilitators
and leading pharmaceutical companies were regularly steering
the development towards greater usability of the tool. In add-
ition to the scheduled usability testing for the TrialViz primary
purpose (feasibility studies for randomized clinical trials), the
tool was also subjected to a usability study on a group of poten-
tial users from a variety of backgrounds: researchers (ﬁve in
each group) in epidemiology, medical statistics, clinical trials sta-
tistics and medical research facilitation. Although the sample
size was limited, the evaluation was carried out mostly at the
qualitative level using interviews and performance observations,
supplemented by questionnaires, ensuring that the results are
still valuable.8 The major aim of this usability study was to
evaluate the suitability of the TrialViz searching facilities and
visualization tool for use in a variety of research contexts in
addition to its primary purpose in RCT. The participants had
varying levels of previous experience working with either
CPRD or The Health Improvement Network (THIN) primary
care database and were recruited from the CPRD itself,
University of Sussex, University College London and King’s
College London. None of the participants had been involved in
the user group or had seen the system before.
The evaluation was based on the human computer interaction
design principles such as visibility, feedback, constraints, affor-
dance and Nielsen’s heuristic evaluation guidance.9 10 Users
were asked to perform a set of typical research scenarios, during
which they were observed, followed by interview and question-
naires commenting on their experience. Most of the output was
qualitative; however, from the quantitative perspective we have
scored users attempting scenarios on a Likert-type psychometric
scale: 1=‘I cannot perform this scenario at all’ to 5=‘I can
perform this scenario easily without any help’. The user inter-
face and visualization tool were also tested using the question-
naire on levels of satisfaction, learnability and functionalities as
follows: Level of satisfaction: 1=very dissatisﬁed, 2=somewhat
dissatisﬁed, 3=neutral, 4=somewhat satisﬁed, 5=very satisﬁed.
Learnability: 1=hard, 2=somewhat hard, 3=neutral,
4=somewhat easy, 5=easy.
Functionality: 1=did not ﬁt the description, 2=missing a
number of important functions, 3=borderline usable, 4=mostly
usable 5=ﬁt the description fully.
The technology acceptance model questionnaire11 was used
to measure perceived usefulness (PU), perceived ease of use
(PEOU) and behavioral intention (BI) of the participants to use
the tool in the future.
RESULTS
Data abstraction
We developed a web portal that allows users to access the entire
database and run complex queries interactively (ﬁgure 2) and to
visualize the results. This interface is based on ‘stacks and
cards’. Each card represents the results of a single query and the
stacks represent a container of cards in which users can place
multiple cards. The stack represents a logical combination of
these cards and has two purposes: it is a visual presentation of
‘set theory’ rules and a means to implement the selection of
date ranges. A search is built up using these cards. Cards are
essentially patient lists representing longitudinal clinical events.
They can be based on code lists, which the user can create them-
selves, or upload and, if required, modify existing ‘public’ code
lists provided by other users or the CPRD (this library of code
lists is an important component of the system). There is a search
facility that allows users, building or modifying code lists to
search for terms or Read codes (eg, ‘diab’ for diabetes or Read
codes beginning with ‘C’). Certain cards can also be based on
test criteria and clinical history (eg, HbA1c or BMI) or indeed
on the results of previous searches (as each search will result in
a patient list which can be represented as a card).
Cards are logically grouped on stacks and (depending on the
type of search) stack represents a union (OR) of the cards it con-
tains while the search represents the intersect (AND) of the par-
ticipating stacks. Conversely, a second search type intersects the
cards on a stack and UNIONs the stacks in the search. There is
also the ability to take the logical NOT of a stack and the user
can therefore logically end up with a set of patients who did
NOT have a particular medical event on a particular date. Users
can create many stacks on the screen, into which they can place
multiple cards. They can specify various demographic ﬁlters (eg,
the age range of the patient) and the date range for events. All
stacks have both absolute and relational date matching. This
allows the cards on the stack to have occurred relative to
another stack as well as occurring absolutely in time.
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Figures 2 and 3 show the results of running a query to select
diabetes patients who do NOT have type 1 diabetes, AND who
have been prescribed either metformin OR sulfonylureas (within
the speciﬁed time), AND who have a speciﬁed level of HbA1c,
AND who have NOT been prescribed insulin and who are NOT
pregnant. Green stacks represent inclusion and red stacks exclu-
sion criteria. The counts for each cumulative result are shown
above the stacks, and the ﬁnal patient count is shown by region
in the map (ﬁgure 3). The colors give a rough indication of the
average number of eligible patients per practice in that region,
with blue representing smaller numbers, and red larger numbers.
The counts represent actual patient lists within the dataset,
representing living patients who adhere to the search criteria at
the time of the latest practice data extraction contributing to the
CPRD version in use (updated monthly). As such, their CPRD
identiﬁers represent potential individuals available for RCT
recruitment selection—given that they are: (a) registered at prac-
tices that contribute data to CPRD; (b) have not exercised their
right to opt out of data collection; and (c) can be contacted by
the GP as an initial step in recruitment. CPRD data are collected
and used in accordance with fully approved governance rules.
The CPRD identiﬁers are a pseudonymized version of patient
system identiﬁers; we can initiate a recruitment process by
sending these to participating practices. This recruitment is pos-
sible now and is functioning successfully in two CPRD-led
proof of concept pragmatic RCTs.12 This methodology has been
subject to full ethical review and within the context of these
studies is good clinical practice compliant. We are conﬁdent
therefore that recruitment based on output from TrialViz will be
acceptable for use in RCT due to the conceptual similarity of
the patient identiﬁcation process with these approved studies.
Data extraction
The TrialViz system is based on a three-database model (ﬁgure 4):
(1) The TrialViz user database, which holds user searches, stack
and card pointers and also contains the functional interface (query
engine) for the TrialViz application. (2) The TrialViz cached results
database, which contains volatile result sets for all cards, stacks
and searches. The query engine checks this cache to see if a result
sets exists (if it does, result sets are returned without continuing)
before querying the CPRD SQL database and building new cached
result sets. (3) The CPRD SQL database, which is a read-only SQL
repository containing all the CPRD anonymized coded patient
event data; this database is queried via user database and returns
result sets to be cached.
We have leveraged the fast input/output speed of solid state
drives to create an optimized SQL-based query-processing tool.
The optimization is based on a divide and execute approach,
and in conjunction with the database model and the underlying
architecture it reduces the search time to seconds rather than
hours or days. Patent is pending (applied for by Dataline
Software) on innovative search algorithms, which allowed this
impressive improvement in query execution time. Search time is
also reduced by using cached results, so if the result set is
already in the cache, the search time will be virtually instant.
We carried out a test of the performance of our query-
processing algorithm versus existing CPRD performance for a
typical simple query: create an intersection of three stacks, con-
taining: (1) patients with asthma-related codelist in clinical
events (returns 10 399 427 rows); (2) patients with arthritis-
related codelist in clinical events (618 728 rows) and (3) patients
with aspirin-related codelist in therapy events (32 516 196
rows). There was a dramatic increase in the performance when
Figure 2 The stack and card interface showing the results of a search for the diabetes example. The counts are cumulative and represent how
many patients are left within the search. RCT, randomized controlled trial.
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our new TrialViz query-processing tool was used: processing
time is reduced from nearly 5 h to 2 s.
Initial investigations indicate that TrialViz, due to its speedy,
near real-time response, compares favorably to other similar
(but much smaller scale) systems with text-based interfaces, such
as IMS disease analyser,13 ePCRN14 and FARSITE;15 however, a
full parameterized benchmarking study was not possible within
the framework of this project.
Data quality assurance
The recording of most measures improved signiﬁcantly over
time, with a noticeable improvement in some measures in 2004
when the UK NHS quality outcomes framework was intro-
duced. In general, data quality in recent years appears to be
good.16 However, there were large variations between practices
and nearly all practice-based variables had very skewed distribu-
tions, with several outliers. This is demonstrated by an example
(ﬁgure 5), which shows the distributions of the percentage (for
each practice) of patients with diabetes who have a code for
type of diabetes. Inter-correlations between variables represent-
ing different categories of measures were generally very weak,
and practices that were poor at recording for one aspect of
quality were almost always very good at recording for other
aspects. Due to the lack of correlations between the practice
variables and inconsistency of poor performance across mea-
sures we decided not to use sophisticated multivariate methods
for combining data quality measures into scores (as was ﬁrst
planned) but to take a more pragmatic approach and, after car-
rying out basic database checks for key measures common to
most studies, to tailor the data quality indicators to the disease
areas of interest. We are currently developing generic programs,
which will enable users to generate sets of data quality
indicators for each contributing GP practice to indicate their
level of suitability for a particular research study. We plan to
incorporate these indicators into TrialViz in due course. In add-
ition, at the request of our users, we have compiled metadata,
which include the unit used, the medians and range, for all the
test results, plus boxplots showing the relative distributions for
each unit used, which we shall make available as an online
manual to users of the system.
User evaluation
Users were asked to perform the following typical scenarios:
1. Create a new search that ﬁts the following criteria: (a) How
many women aged 25–45 years are in the database, who
have been diagnosed with ovarian cancer; (b) how many
women have been diagnosed with ovarian cancer and had
abdominal pain.
2. Create a new search answering how many patients are born
before the year 2000 and had an event of either abdominal
pain or abdominal distension.
3. Create a new ‘Medical codelist card’ that contains the Read
code C10.00 (diabetes mellitus) and ﬁnd out how many
people aged 18 years and older have been diagnosed with it.
The average score for the scenarios performed on TrialViz
Beta V.3.1 was 4.89= ‘I can perform this scenario easily
without any help/ minimal help’.
We also undertook a technology acceptance model analysis
based on users’ interview results:11
PA ¼ PUþ PEOU
BI ¼ PAþ PU;
where the coefﬁcients PU and PEOU were derived from the
Figure 3 Visualization of patient number on map for the diabetes example.
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evaluation questionnaire (see table 1) and cross-referenced with
interviews. As we can see from table 2, personal attitude (PA)
towards the tool was very positive (derived from Likert-based
scores from PU and PEOU), inﬂuencing the possibility to adopt
the tool in the future in their work activities BI.
As shown in tables 1 and 2, users were satisﬁed overall with
TrialViz and indicated a strong interest in adopting TrialViz in
their work in the future. Open-ended questions also indicated
that the users found TrialViz’s search interface and code list
facilities intuitive, memorable and easy to learn. They were also
impressed with the range of functionality offered. The most
praised feature of the tool was its fast performance of searches,
unmatched by other currently available medical database search
tools. However, the users indicated that visualization of search
results could be more extensive and that a feature of exporting
search results to a variety of formats would be useful.
DISCUSSION
Protocols for RCT are typically based on a large number of
inclusion and exclusion criteria and the queries may be very
complex. The ﬂexible design, and three-database model (only
one of which is dependent on the core database) means that it
can be easily adapted for many other applications. By working
on a generic core dataset, TrialViz could be developed to work
with any large-scale electronic data. Such data resources are
now a major focus within healthcare research and with their
increased use the importance of the core data quality method-
ology will rise. Consequently, this will open up a plethora of
parallel applications for the generic approach being developed
within this project. Apart from the more obvious applications
for health services research, current additional applications
include the use of data quality scores in terms of observational
data studies to model uncertainty in data. The application of the
methodology per se is important in obtaining the strategies to
assess the quality and usefulness of routinely collected data in
terms of various spheres of research. Furthermore, sister systems
to the one proposed could be easily developed to facilitate feed-
back to the data collecting entities (general practices in this
Figure 5 Boxplots showing the distribution of the proportion of patients (per GP practice) with a ﬁrst diagnosis code for diabetes in each year
whose type had been recorded at some point in their record.
Figure 4 The three-database model that was used for TrialViz. CPRD,
Clinical Practice Research Datalink; DB, database.
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case), which may act as a positive feedback mechanism for the
enhancement of data quality at source.
CONCLUSIONS
In this paper we presented the development of a system
(TrialViz), which allows users to interrogate a large database of
patient records and to visualize the results of complex queries in
near real time. This represents a considerable advance over most
other currently available systems. Our query-processing tool
offers opportunities for exploring the data in ways that could
never have been envisaged before and also delivering informa-
tion in real or near real time. The TrialViz system identiﬁes indi-
viduals potentially available for study recruitment, representing
a signiﬁcant advantage over other systems that investigate
general rates of disease or patient availability within geograph-
ical areas. TrialViz facilitates interaction with potential study
participants via their GP. TrialViz was developed independently
from the development of CPRD as an organization; however, its
scope aligns well with CPRD objectives and as such will be
incorporated into the suite of tools taken forward under the
umbrella of CPRD services.
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Table 1 Questionnaire results for general usability of the TrialViz
tool
System
Level of
satisfaction
(1=least–5=very)
Learnability
(1=hard–
5=easy)
Functionalities (1=did
not fit description–5=fit
description)
TrialViz 3.91 4.38 4.58
Table 2 TAM analysis for TrialViz tool.
System
PU
(maximum 5)
PEOU
(maximum 5)
PA (maximum
10)
BI (maximum
15)
TrialViz 3.67 4.5 8.17 11.84
BI, behavioral intention; PA, personal attitude; PEOU, perceived ease of use; PU,
perceived usefulness.
Tate AR, et al. J Am Med Inform Assoc 2013;0:1–7. doi:10.1136/amiajnl-2013-001847 7
Research and applications
 group.bmj.com on November 25, 2013 - Published by jamia.bmj.comDownloaded from 
doi: 10.1136/amiajnl-2013-001847
 published online November 22, 2013J Am Med Inform Assoc
 
A Rosemary Tate, Natalia Beloff, Balques Al-Radwan, et al.
 
intuitive query interface
using rapid search algorithms and an
of electronic health records for research 
Exploiting the potential of large databases
 http://jamia.bmj.com/content/early/2013/11/22/amiajnl-2013-001847.full.html
Updated information and services can be found at: 
These include:
References
 http://jamia.bmj.com/content/early/2013/11/22/amiajnl-2013-001847.full.html#ref-list-1
This article cites 9 articles, 4 of which can be accessed free at:
Open Access
non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
terms, provided the original work is properly cited and the use is
work non-commercially, and license their derivative works on different 
license, which permits others to distribute, remix, adapt, build upon this
Creative Commons Attribution Non Commercial (CC BY-NC 3.0) 
This is an Open Access article distributed in accordance with the
P<P Published online November 22, 2013 in advance of the print journal.
service
Email alerting
the box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in
(DOIs) and date of initial publication. 
publication. Citations to Advance online articles must include the digital object identifier 
citable and establish publication priority; they are indexed by PubMed from initial
typeset, but have not not yet appeared in the paper journal. Advance online articles are 
Advance online articles have been peer reviewed, accepted for publication, edited and
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on November 25, 2013 - Published by jamia.bmj.comDownloaded from 
Collections
Topic
 (127 articles)Open access   
 
Articles on similar topics can be found in the following collections
Notes
(DOIs) and date of initial publication. 
publication. Citations to Advance online articles must include the digital object identifier 
citable and establish publication priority; they are indexed by PubMed from initial
typeset, but have not not yet appeared in the paper journal. Advance online articles are 
Advance online articles have been peer reviewed, accepted for publication, edited and
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on November 25, 2013 - Published by jamia.bmj.comDownloaded from 
